What information must be included in the Parkinson's Disease Registry report?

The requirement to include the name and address of the patient prescribed drugs in the Parkinson's Disease Registry report is grounded in the necessity to accurately identify individuals receiving treatment for the condition. This information is essential for tracking the prevalence of Parkinson's disease, understanding treatment outcomes, and conducting research that could lead to better management of the disease. The specificity of including the patient's identifying information helps ensure that the data collected is reliable, allowing for effective analysis and policy-making.

While other details such as the prescribing physician's license number, the patient's family history, and demographic factors like age and gender can indeed contribute valuable context, the primary aim of the registry is to monitor treatment patterns and outcomes tied directly to individual patients. Thus, having the name and address ensures that each case can be linked effectively to corresponding clinical data, which is critical for maintaining the integrity and usefulness of the registry.